Phase 3, ongoing process verification: Guide to validation of terminal sterilization process of drugs (GUI-0074)

On this page

Routine release

You should:

For more information on reprocessing and reworking, consult:

For guidance on parametric release, consult:

Monitoring results

You should:

Include in the validation protocol the requirement for and adherence to effective, routine process-monitoring procedures.

You should also:

Note: Sterilization has not been achieved if there is a growth of any biological challenge organisms after moist heat and EO sterilization, including documented change control evaluation runs. If this occurs, you must evaluate the process parameters. If you cannot find a processing error, you must consider the sterilization process unacceptable.

Periodic review and revalidation

You should:

Change management system

An effective change management system involves evaluating, approving, implementing and documenting sterilization systems or product changes. Include documentation of any testing required to ensure the qualified state of control.

You should:

Note: You may not need to revalidate the modified sterilization process if you can demonstrate the product/material, packaging, load configuration, equipment or process equivalence. The process is considered equivalent if it runs within the defined, validated process limits.

You must conduct a technical review that compares the modification candidate with the product/material, packaging, load configuration, equipment or process used to validate the existing sterilization process. You must then document the outcome of this review and include the rationale for any decisions made as a result.

Page details

Date modified: